Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2005
08/31/2005CN1216911C Recombinant human interleukin-4, its code nucleic acid and its applicaton
08/31/2005CN1216910C Novel liver regeneration related protein, its code sequence and application
08/31/2005CN1216909C Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
08/31/2005CN1216908C Arabidopsis thaliana BVD1 gene and its use
08/31/2005CN1216907C Adverse-resistance transcription factor from tomato, its coding gene and application
08/31/2005CN1216906C Transcription factor capable of regulating and controlling soybean adverse resistance, its coding gene and application
08/31/2005CN1216905C Transcription factor for regulating and controlling dry land cotton anti contrary property and its coded gene and application
08/31/2005CN1216904C Soybean ethylene response protein transcription factor and its coded gene and application
08/31/2005CN1216903C Ethylene response conjugated protein transcription factor of ice plant and tis coded gene and application
08/31/2005CN1216902C Specific protein of SARS virus, clinical detection method and kit
08/31/2005CN1216901C Method for cleaving chimeric protein using processing enzyme
08/31/2005CN1216900C Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
08/31/2005CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease
08/30/2005US6936750 Isolated nucleic acid molecules encoding Na+/H+ exchanger polypeptides for extrusion of monovalent cations, most preferably sodium ions from the cytosol of cells to provide the cell with increased salt tolerance
08/30/2005US6936749 Nonsymbiotic plant hemoglobins to maintain cell energy status
08/30/2005US6936708 Expression of Alfin 1 and methods for producing transgenic plants having increased root growth and root specific gene activation
08/30/2005US6936707 Modified DNA molecule, recombinant containing the same, and uses thereof
08/30/2005US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
08/30/2005US6936703 Biocatalyst inhibitors
08/30/2005US6936697 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/30/2005US6936696 Modified proteins having an increased number of essential amino acids; transformed host cells, transgenic plants and seeds containing the enhanced proteins, and methods for preparing and using them
08/30/2005US6936695 Manufacture and expression of large structural genes
08/30/2005US6936694 [Met--1, des-Cys1, des-Tyr2, des-Cys3]IFN- gamma polypeptide produced by a DNA sequence coding in a transformant organism, and such polypeptide having the characteristics of human immune interferon
08/30/2005US6936693 Specific polypeptides, useful as nematocides
08/30/2005US6936692 Binding antibodies; culture product; gene therapy; chromosome mapping
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936690 Molecules of the card-related protein family and uses thereof
08/30/2005US6936689 Peptide antagonists of zonulin and methods for use of the same
08/30/2005US6936688 Nucleotide sequences coding polypeptide for use in the treatment of leukemia, tumors, infections, autoimmune disease, and fibrotic disorders; wound healing agent
08/30/2005US6936586 interleukin 10 (IL-10) agonists; treatment of pancreatitis, arthritis, gout, allergies, inflammations and ischemias; polypeptides
08/30/2005US6936585 Corticotropin releasing factor 2 receptor agonists
08/30/2005US6936584 Mixed amylin activity compounds
08/30/2005US6936475 Hybrid green fluorescent protein (GFP) which binds, measures and detects calcium using fluorescent/chemiluminescence resonance energy transfer (F/CRET)
08/30/2005US6936466 Nucleotide sequences coding polypeptide for use in the treatment of hereditary respiratory system disorders
08/30/2005US6936465 Plasmid vector comprising a retroviral integrase gene and an integrase recognition region
08/30/2005US6936458 Isolated DNA comprising one or more genes specific for 5S clavam biosynthesis, vectors comprising such DNA and streptomyces hosts capable of improved clavulanic acid production
08/30/2005US6936457 DNA ENCODING HUMAN α AND β SUBUNITS OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR, CELLS TRANSFORMED THEREWITH, AND RECOMBINANT CELL LINE EXPRESSING A HUMAN α AND β SUBUNIT OF NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR
08/30/2005US6936449 Regulatable growth of filamentous fungi
08/30/2005US6936443 Detection and typing of human papillomavirus using PNA probes
08/30/2005US6936440 Selecting ligand agonists and antagonists
08/30/2005US6936439 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity
08/30/2005US6936437 Solubilizing and recovering genetically engineered troponin produced as inclusion bodies
08/30/2005US6936436 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
08/30/2005US6936435 Compositions and methods for regulating bacterial pathogenesis
08/30/2005US6936431 Anticancer, antitumor agents; measuring farnesylation of cellular protein
08/30/2005US6936428 Genetic engineering; bonding polypeptides, labeling, insertion into cell
08/30/2005US6936425 Attenuated salmonella SP12 mutants as antigen carriers
08/30/2005US6936424 Materials and methods for detection and treatment of breast cancer
08/30/2005US6936423 Anti-LTNF for in vitro assay of biological toxins
08/30/2005US6936422 Staphylococcus culture; genetic engineering
08/30/2005US6936421 Structurally biased random peptide libraries based on different scaffolds
08/30/2005US6936271 Biocompatible carrier medium such as a saline or dextran solution and particles of collagenous material dispersed therein; injectable form or as a paste; use in cosmetic and reconstruction surgery, or as antiscarring agent
08/30/2005US6936263 Th1 inducing natural adjuvant for heterologous antigens
08/30/2005US6936262 Animal feeds; pneumonia vaccine
08/30/2005US6936261 Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
08/30/2005US6936259 For therapy and prophylaxis of bacterial infections
08/30/2005US6936258 Staphylococcus antigen and vaccine
08/30/2005US6936257 Recombinant Venezuelan equine encephalitis virus vaccine
08/30/2005US6936256 For controlling Infectious Pancreatic Necrosis Virus (IPNV) in aquatic species
08/30/2005US6936254 Method of inducing fetal hemoglobin synthesis
08/30/2005US6936252 Streptococcus pneumoniae proteins and nucleic acid molecules
08/30/2005US6936251 Detection using antibodies
08/30/2005US6936247 Filariid anti-P22U antibodies
08/30/2005US6936246 Passive immunization of ASCR for prion disorders
08/30/2005CA2294647C Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/30/2005CA1341490C Dna functional group and plasmid coding for hirudine, transformed yeast, preparation process for hirudine, resulting hirudine, and its pharmaceutical use
08/30/2005CA1341489C Family of primate hematopoietic growth factors
08/30/2005CA1341488C Precursor antigens for human retorvirus (hiv-2) envelope glycoproteins, and immunologically related antigens
08/27/2005WO2005076696A2 Pneumolysin derivatives
08/27/2005CA2555803A1 Pneumolysin derivatives
08/25/2005WO2005078848A2 Inhibition of tumor growth and invasion by anti-matrix metalloproteinase dnazymes
08/25/2005WO2005078119A1 Probe for detecting nuclear receptor agonist or antagonist and method of screening agonist or antagonist to nuclear receptor with the use of the same
08/25/2005WO2005078116A1 A method of isolating antibacterial peptides and the isolated peptides thereof
08/25/2005WO2005078106A1 Orotate transporter encoding marker genes
08/25/2005WO2005078105A2 Selection markers useful for heterologous protein expression
08/25/2005WO2005078101A2 Use of genes encoding outward potassium channels for modifying at least one phenotype linked to the size and organic acid content of at least one plant storage organ
08/25/2005WO2005078099A1 Mecp2e1 gene
08/25/2005WO2005078085A1 Polypeptide having collagen-like structure
08/25/2005WO2005078076A2 Tpl2 and its expression
08/25/2005WO2005078075A2 Hybrid proteins of active-site serine beta-lactamase
08/25/2005WO2005077980A2 Soluble tcr-like molecules and their uses
08/25/2005WO2005077977A2 Carcinoembryonic antigen fusions proteins and uses thereof
08/25/2005WO2005077976A2 Coiled-coil domains from c4b-binding protein
08/25/2005WO2005077975A2 Polypeptides comprising the pleckstrin homology domain of ect2 and their binding specificities to phosphatidylinositols
08/25/2005WO2005077974A1 IDENTIFICATION OF SNPs ASSOCIATED WITH HYPERLIPIDEMIA, DYSLIPIDEMIA AND DEFECTIVE CARBOHYDRATE METABOLISM
08/25/2005WO2005077973A1 Purification of recombinant human proteins
08/25/2005WO2005077972A1 Ornithobacterium rhinotracheale subunit vaccines
08/25/2005WO2005077971A1 Novel heparin-binding peptide designed from heparin-binding site of snake poison-origin vascular endothelial growth factor (vegf)-like protein and use tehreof
08/25/2005WO2005077970A1 Novel heparin-binding peptide designed from heparin-binding site of snake venom-origin vascular endothelial growth factor (vegf)-like protein and use thereof
08/25/2005WO2005077969A2 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
08/25/2005WO2005077421A1 A method of preparing polyethylene glycol modified interferon alpha 1b
08/25/2005WO2005077416A2 Lipid rafts and clostridial toxins
08/25/2005WO2005077415A1 Pharmaceutical composition for treatment of immunological disorders
08/25/2005WO2005077408A2 Compositions of pamps and listeria monocytogenes and methods of use
08/25/2005WO2005077201A1 Preparation of canola protein isolate and use in aquaculture
08/25/2005WO2005077105A2 Reduction of hiv-1 replication by a mutant apolipoprotein b mrna editing enzyme-catalytic polypeptide-like 3 g (apobec3g)
08/25/2005WO2005077099A2 Reduction of hiv-1 replication by a mutant apolipoprotein b mrna editing enzyme-catalytic polypeptide-like 3 g (apobec3g)
08/25/2005WO2005077095A2 Ccn1 transgenic animals
08/25/2005WO2005077094A2 Pancreatic polypeptide family motifs and polypeptides comprising the same
1 ... 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 ... 2916